Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)
Following FDA, CHMP gives thumbs-up on Pfizer, BioNTech Omicron booster
One day after the FDA cleared Pfizer’s bivalent booster to go after Omicron, the pharma giant and its partners at BioNTech are now one step …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
